RIO DE JANEIRO, BRAZIL - (Reuters) Negotiations between Peru and China’s Sinopharm to purchase COVID-19 vaccines are “well advanced,” the government said on Tuesday, as the hard-hit Andean nation scrambles to lock down supplies to combat the virus.
The announcement comes just days after local authorities temporarily suspended a 12,000 participant trial for the Chinese firm´s vaccine after a volunteer fell ill. The case is still under investigation.
“The negotiations with ... Sinopharm are well advanced, with {only} minor details to be verified,” Peruvian Foreign Minister Elizabeth Astete told a legislative commission.
Astete said Peru had also . . .
To read the full NEWS and much more, Subscribe to our Premium Membership Plan. Already Subscribed? Login Here